Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hepatitis

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 116 articles:
HTML format



Single Articles


    June 2021
  1. SCHAEFER EAK
    A Deep Ravine Rather Than a Shallow Gap: Many More Bridges Needed to Improve Care of Chronic Hepatitis B in the United States.
    Am J Gastroenterol. 2021 Jun 30. pii: 00000434-990000000-00023.
    PubMed     Abstract available


  2. YU X
    Pay Attention to Distinguish Hepatitis from Novel Coronavirus Hepatitis in the Context of COVID-19 Pandemic.
    Am J Gastroenterol. 2021;116:1354-1355.
    PubMed    


  3. RINALDI L, Messina V, Di Marco V, Iovinella V, et al
    Factors Enhancing Treatment of Hepatitis C Virus-Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience.
    Am J Gastroenterol. 2021;116:1248-1255.
    PubMed     Abstract available


  4. NGUYEN MH, Atsukawa M, Ishikawa T, Yasuda S, et al
    Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir.
    Am J Gastroenterol. 2021;116:1264-1273.
    PubMed     Abstract available


    April 2021
  5. TRAN S, Jeong D, Henry L, Cheung RC, et al
    Initial Evaluation, Long-Term Monitoring, and Hepatocellular Carcinoma Surveillance of Chronic Hepatitis B in Routine Practice: A Nationwide US Study.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98796.
    PubMed     Abstract available


  6. SHARMA S, Saraya A
    Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet?
    Am J Gastroenterol. 2021 Apr 9. pii: 00000434-900000000-98829.
    PubMed    


  7. JI D, Chen Y, Shang Q, Liu H, et al
    Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98824.
    PubMed     Abstract available


  8. KHALILI M, Kleiner DE, King WC, Sterling RK, et al
    Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98823.
    PubMed     Abstract available


  9. EISA M, Kennedy R, Teferra R, Heckroth M, et al
    SARS-COV-2 Infection in Patients With Alcohol-Associated Hepatitis: Metabolic Similarities and Treatment Challenges.
    Am J Gastroenterol. 2021;116:847-848.
    PubMed    


    March 2021
  10. NAM H, Lee SW, Kwon JH, Lee HL, et al
    Prediction of Hepatocellular Carcinoma by On-Therapy Response of Noninvasive Fibrosis Markers in Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Mar 10. pii: 00000434-900000000-98856.
    PubMed     Abstract available


    February 2021
  11. TOSETTI G, Degasperi E, Farina E, D'Ambrosio R, et al
    Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Beta-Blocker Therapy.
    Am J Gastroenterol. 2021 Feb 18. pii: 00000434-900000000-98881.
    PubMed     Abstract available


  12. TAN HK, Teng MLP, Soh AYS, Cheo SHY, et al
    Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites.
    Am J Gastroenterol. 2021 Feb 1. doi: 10.14309/ajg.0000000000001176.
    PubMed     Abstract available


    January 2021
  13. WONG GL, Wong VW, Hui VW, Yip TC, et al
    Hepatitis Flare During Immunotherapy in Patients With Current or Past Hepatitis B Virus Infection.
    Am J Gastroenterol. 2021 Jan 28. pii: 00000434-900000000-98894.
    PubMed     Abstract available


  14. XU J, Liang X, Cai X
    A Ring in the Liver.
    Am J Gastroenterol. 2021;116:220-222.
    PubMed    


    December 2020
  15. LI J, Gordon SC, Zhou Y, Boscarino JA, et al
    Sex Differences in Extrahepatic Outcomes After Antiviral Treatment for Hepatitis C.
    Am J Gastroenterol. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  16. DESAI N, Rich NE, Jain MK, Blackwell JM, et al
    Randomized Clinical Trial of Inreach With or Without Mailed Outreach to Promote Hepatitis C Screening in a Difficult-to-Reach Patient Population.
    Am J Gastroenterol. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  17. MCCLAIN CJ, Vatsalya V, Mitchell MC
    Keratin-18: Diagnostic, Prognostic, and Theragnostic for Alcohol-Associated Hepatitis.
    Am J Gastroenterol. 2020 Dec 10. doi: 10.14309/ajg.0000000000001042.
    PubMed     Abstract available


  18. FABIANA B, Cesar A, Marcio C, Carolina M, et al
    P061 Prophylaxis of Hepatitis B Reactivation and Inflammatory Bowel Disease: A case report.
    Am J Gastroenterol. 2020;115.
    PubMed    


    November 2020
  19. ATKINSON SR, Grove JI, Liebig S, Astbury S, et al
    In Severe Alcoholic Hepatitis, Serum Keratin-18 Fragments Are Diagnostic, Prognostic, and Theragnostic Biomarkers.
    Am J Gastroenterol. 2020;115:1857-1868.
    PubMed     Abstract available


  20. CHAPARRO M, Gordillo J, Domenech E, Esteve M, et al
    Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial.
    Am J Gastroenterol. 2020;115:1802-1811.
    PubMed     Abstract available


  21. BANTY A, Melmed GY
    Improving Hepatitis B Virus Vaccination Responses in Inflammatory Bowel Disease: Does Greater Dose and Greater Frequency Lead to Greater Protection?
    Am J Gastroenterol. 2020;115:1797-1798.
    PubMed     Abstract available


  22. SANTOS S, Simoes G, Lemos J, Saiote J, et al
    Long-Term Self-Expandable Metal Stent (SEMS) for Esophageal Variceal Bleeding: A Picture of the Natural History.
    Am J Gastroenterol. 2020;115:1915-1917.
    PubMed     Abstract available


    October 2020
  23. LV XH, Yang JL, Deng K
    COVID-19 Patients With Hepatitis B Virus Infection.
    Am J Gastroenterol. 2020 Oct 26. doi: 10.14309/ajg.0000000000001034.
    PubMed    


  24. EISA M, Kennedy R, Teferra R, Heckroth M, et al
    SARS-COV-2 Infection in Patients With Alcohol-Associated Hepatitis: Metabolic Similarities and Treatment Challenges.
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000001002.
    PubMed    


  25. SINN DH, Kang D, Guallar E, Chang Y, et al
    Alcohol Intake and Mortality in Patients With Chronic Viral Hepatitis: A Nationwide Cohort Study.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000966.
    PubMed     Abstract available


  26. DA BL, Rahman F, Lai WC, Kleiner DE, et al
    Risk Factors for Delta Hepatitis in a North American Cohort: Who Should Be Screened?
    Am J Gastroenterol. 2020 Oct 7. doi: 10.14309/ajg.0000000000000954.
    PubMed     Abstract available


  27. ATKINSON SR, Grove JI, Liebig S, Astbury S, et al
    In Severe Alcoholic Hepatitis, Serum Keratin-18 Fragments Are Diagnostic, Prognostic, and Theragnostic Biomarkers.
    Am J Gastroenterol. 2020 Oct 1. doi: 10.14309/ajg.0000000000000912.
    PubMed     Abstract available


  28. SHARMA S, Agarwal S, Gunjan D, Kaushal K, et al
    Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort.
    Am J Gastroenterol. 2020;115:1650-1656.
    PubMed     Abstract available


    September 2020
  29. CHAPARRO M, Gordillo J, Domenech E, Esteve M, et al
    Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial.
    Am J Gastroenterol. 2020 Sep 30. doi: 10.14309/ajg.0000000000000926.
    PubMed     Abstract available


  30. BANTY A, Melmed GY
    Improving Hepatitis B Virus Vaccination Responses in Inflammatory Bowel Disease: Does Greater Dose and Greater Frequency Lead to Greater Protection?
    Am J Gastroenterol. 2020 Sep 25. doi: 10.14309/ajg.0000000000000921.
    PubMed     Abstract available


  31. HE Q, Zhang G, Gu Y, Wang J, et al
    Clinical Characteristics of COVID-19 Patients With Pre-existing Hepatitis B Virus Infection: A Multicenter Report.
    Am J Gastroenterol. 2020 Sep 11. doi: 10.14309/ajg.0000000000000924.
    PubMed    


    August 2020
  32. TEH KK, Soh NY, Lim KW, Ng KY, et al
    Use of Percutaneous Radiofrequency Ablation in Paracentesis-Related Intraperitoneal Hemorrhage From a Bleeding Abdominal Wall Vessel.
    Am J Gastroenterol. 2020;115:1299-1300.
    PubMed    


    July 2020
  33. SAINATH KG, Vasan A, Singh V
    Serum Transferrin Is an Independent Predictor of Mortality in Severe Alcoholic Hepatitis: Upping the Game or Just Upping the Ante?
    Am J Gastroenterol. 2020;115:1136.
    PubMed    


  34. HAO SR, Zhang SY, Lian JS, Jin X, et al
    Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study.
    Am J Gastroenterol. 2020;115:1075-1083.
    PubMed     Abstract available


  35. THULUVATH PJ, Bruno DA, Alukal J, Satapathy SK, et al
    Use of HCV-Positive Livers in HCV-Negative Recipients.
    Am J Gastroenterol. 2020;115:1045-1054.
    PubMed     Abstract available


  36. POLANCO NP, Goldberg D
    Transplanting Livers From "HCV-Positive" Donors To HCV-Negative Recipients: Increased Experience But Many Unanswered Questions.
    Am J Gastroenterol. 2020;115:1022-1023.
    PubMed     Abstract available


  37. ATKINSON SR, Thursz MR, Strnad P
    Response to Sainath et al.
    Am J Gastroenterol. 2020;115:1136-1137.
    PubMed    


  38. RUBIN JN, Gilman CAL, Gasmi B, Stern WR, et al
    Hepatocellular Carcinoma Where You Least Expect It.
    Am J Gastroenterol. 2020;115:1134-1136.
    PubMed    


    June 2020
  39. LIM JK, Nguyen MH, Kim WR, Gish R, et al
    Prevalence of Chronic Hepatitis B Virus Infection in the United States.
    Am J Gastroenterol. 2020 Jun 1. doi: 10.14309/ajg.0000000000000651.
    PubMed     Abstract available


  40. ATKINSON SR, Thursz MR, Strnad P
    Response to Diao et al.
    Am J Gastroenterol. 2020;115:958.
    PubMed    


    May 2020
  41. SAKAI N, Kamimura K, Terai S
    Multiple Tumor-Like Fatty Changes in the Liver Disappeared After Hepatitis C Virus Eradication With Direct-Acting Antiviral Treatment.
    Am J Gastroenterol. 2020 May 22. doi: 10.14309/ajg.0000000000000703.
    PubMed    


  42. POLANCO NP, Goldberg D
    Transplanting Livers From "HCV-Positive" Donors To HCV-Negative Recipients: Increased Experience But Many Unanswered Questions.
    Am J Gastroenterol. 2020 May 20. doi: 10.14309/ajg.0000000000000649.
    PubMed     Abstract available


  43. YIM HJ, Kim W, Ahn SH, Yang JM, et al
    Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial.
    Am J Gastroenterol. 2020 May 1. doi: 10.14309/ajg.0000000000000605.
    PubMed     Abstract available


  44. SANDY NS, Hessel G, Bellomo-Brandao MA
    Major Complications of Pediatric Percutaneous Liver Biopsy Do Not Differ Among Physicians With Different Degrees of Training.
    Am J Gastroenterol. 2020;115:786-789.
    PubMed     Abstract available


    April 2020
  45. SAINATH KG, Vasan A, Singh V
    Serum Transferrin Is an Independent Predictor of Mortality in Severe Alcoholic Hepatitis: Upping the Game or Just Upping the Ante?
    Am J Gastroenterol. 2020 Apr 23. doi: 10.14309/ajg.0000000000000657.
    PubMed    


  46. WANDER P, Epstein M, Bernstein D
    COVID-19 Presenting as Acute Hepatitis.
    Am J Gastroenterol. 2020 Apr 15. doi: 10.14309/ajg.0000000000000660.
    PubMed    


  47. DIAO YK, Jia HD, Huang DS, Zhang CW, et al
    Is Serum Transferrin an Independent Predictor of Mortality in Severe Alcoholic Hepatitis?
    Am J Gastroenterol. 2020 Apr 15. doi: 10.14309/ajg.0000000000000601.
    PubMed    


    March 2020
  48. HUANG CF, Lai HC, Chen CY, Tseng KC, et al
    Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
    Am J Gastroenterol. 2020 Mar 26. doi: 10.14309/ajg.0000000000000606.
    PubMed     Abstract available


  49. CHAN TT, Chan WK, Wong GL, Chan AW, et al
    Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2020 Mar 9. doi: 10.14309/ajg.0000000000000588.
    PubMed     Abstract available


  50. THULUVATH PJ, Bruno DA, Alukal J, Satapathy SK, et al
    Use of HCV-Positive Livers in HCV-Negative Recipients.
    Am J Gastroenterol. 2020 Mar 3. doi: 10.14309/ajg.0000000000000583.
    PubMed     Abstract available


    February 2020
  51. MOON AM, Spiritos Z, King LY, Barritt AS 4th, et al
    Immunosuppression in Autoimmune Hepatitis: Is There an End Game?
    Am J Gastroenterol. 2020 Feb 6. doi: 10.14309/ajg.0000000000000538.
    PubMed    


    January 2020
  52. ATKINSON SR, Hamesch K, Spivak I, Guldiken N, et al
    Serum Transferrin Is an Independent Predictor of Mortality in Severe Alcoholic Hepatitis.
    Am J Gastroenterol. 2020 Jan 24. doi: 10.14309/ajg.0000000000000492.
    PubMed     Abstract available


  53. HSU YC, Nguyen MH
    Inhibitory Effect of Nucleos(t)ide Analogs on Telomerase Activity and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Am J Gastroenterol. 2020 Jan 6. doi: 10.14309/ajg.0000000000000507.
    PubMed    


  54. CHOI J, Kim GA, Han S, Lim YS, et al
    Earlier Alanine Aminotransferase Normalization During Antiviral Treatment Is Independently Associated With Lower Risk of Hepatocellular Carcinoma in Chronic Hepatitis B.
    Am J Gastroenterol. 2020 Jan 2. doi: 10.14309/ajg.0000000000000490.
    PubMed     Abstract available


    December 2019
  55. ARSLAN F, Vahaboglu H
    Tenofovir for the Prevention of HCC in Patients With Cirrhosis.
    Am J Gastroenterol. 2019 Dec 16. doi: 10.14309/ajg.0000000000000477.
    PubMed    


  56. MORALES-ARRAEZ D, Hernandez-Guerra M
    Electronic Alerts as a Simple Method for Amplifying the Yield of Hepatitis C Virus Infection Screening and Diagnosis.
    Am J Gastroenterol. 2019 Dec 11. doi: 10.14309/ajg.0000000000000487.
    PubMed    


    November 2019
  57. KIDAMBI TD, Chu P, Lee JK, Lin JL, et al
    Immunotherapy-Associated Pseudomembranous Colitis.
    Am J Gastroenterol. 2019;114:1708.
    PubMed    


    October 2019
  58. ZHOU K, Wahed AS, Cooper S, Di Bisceglie AM, et al
    Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia.
    Am J Gastroenterol. 2019 Oct 24. doi: 10.14309/ajg.0000000000000400.
    PubMed     Abstract available


  59. HSU YC, Wong GL, Chen CH, Peng CY, et al
    Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B.
    Am J Gastroenterol. 2019 Oct 11. pii: 00000434-900000000-00005.
    PubMed     Abstract available


    August 2019
  60. YOUNOSSI ZM, Stepanova M, Lawitz EJ, Reddy KR, et al
    Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life.
    Am J Gastroenterol. 2019 Aug 20. doi: 10.14309/ajg.0000000000000375.
    PubMed     Abstract available


  61. CALVARUSO V, Cacciola I, Licata A, Madonia S, et al
    Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL Experience.
    Am J Gastroenterol. 2019;114:1275-1282.
    PubMed     Abstract available


    July 2019
  62. STEWART OA, Kingsbery J, Chang S
    Outbreak in New York! Measles Hepatitis.
    Am J Gastroenterol. 2019 Jul 16. doi: 10.14309/ajg.0000000000000325.
    PubMed    


    May 2019
  63. PEARLMAN B, Perrys M, Hinds A
    Sofosbuvir/Velpatasvir/Voxilaprevir for Previous Treatment Failures With Glecaprevir/Pibrentasvir in Chronic Hepatitis C Infection.
    Am J Gastroenterol. 2019 May 8. doi: 10.14309/ajg.0000000000000248.
    PubMed     Abstract available


  64. BZOWEJ NH, Tran TT, Li R, Belle SH, et al
    Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study.
    Am J Gastroenterol. 2019 May 1. doi: 10.14309/ajg.0000000000000221.
    PubMed     Abstract available


    April 2019
  65. KIM AY
    Hepatitis B Virus and HIV Coinfection: Fibrosis, Fat, and Future Directions.
    Am J Gastroenterol. 2019 Apr 12. doi: 10.14309/ajg.0000000000000231.
    PubMed     Abstract available


    January 2019
  66. LIN PA, Tseng SH, Huang YH
    Corneal Transplantation From Donors With Hepatitis B: Preliminary Results.
    Am J Gastroenterol. 2019 Jan 18. doi: 10.14309/ajg.0000000000000052.
    PubMed    


  67. LAIQUE SN, Vargas HE
    Hepatitis C Virus: No Longer a Barrier to Oncology Care.
    Am J Gastroenterol. 2019 Jan 18. doi: 10.14309/ajg.0000000000000095.
    PubMed     Abstract available


  68. FORREST EH, Atkinson SR, Richardson P, Masson S, et al
    ACG Clinical Guideline for Alcoholic Liver Disease: The MELD Threshold for Corticosteroid Treatment has Yet to be Established.
    Am J Gastroenterol. 2019;114:175-176.
    PubMed    


    November 2018
  69. STERLING RK, Wahed AS, King WC, Kleiner DE, et al
    Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study.
    Am J Gastroenterol. 2018 Nov 8. pii: 10.1038/s41395-018-0409.
    PubMed     Abstract available


  70. TORRES HA, Economides MP, Angelidakis G, Hosry J, et al
    Sofosbuvir-Based Therapy in Hepatitis C Virus-infected Cancer Patients: A Prospective Observational Study.
    Am J Gastroenterol. 2018 Nov 8. pii: 10.1038/s41395-018-0383.
    PubMed     Abstract available


    October 2018
  71. PAN XB, Lu YQ, Lin SZ, Ye J, et al
    An Assessment of Upper Limits of Normal for ALT and the Impact on Evaluating Natural Course of Chronic Hepatitis B Virus Infection in Chinese Children.
    Am J Gastroenterol. 2018 Oct 23. pii: 10.1038/s41395-018-0248.
    PubMed     Abstract available


  72. YEE HS, Burton MJ, Belperio PS, Morgan TR, et al
    The Veterans Affairs Hepatitis C Treatment Considerations.
    Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0231.
    PubMed    


  73. YIP TC, Chan HL, Tse YK, Lam KL, et al
    On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis.
    Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0247.
    PubMed     Abstract available


    July 2018
  74. REDMAN JS, Sterling RK
    Treating HCV in a Captive Audience: Eradication Efforts in the Prison Microenvironment.
    Am J Gastroenterol. 2018 Jul 24. pii: 10.1038/s41395-018-0201.
    PubMed     Abstract available


  75. YOUNOSSI ZM
    Disparities in Access to Direct Acting Antiviral Regimens for Hepatitis C Virus (HCV): The Impact of Race and Insurance Status.
    Am J Gastroenterol. 2018 Jul 18. pii: 10.1038/s41395-018-0200.
    PubMed     Abstract available


  76. ACHARYA C, Bajaj JS
    Current Management of Hepatic Encephalopathy.
    Am J Gastroenterol. 2018 Jul 13. pii: 10.1038/s41395-018-0179.
    PubMed     Abstract available


    June 2018
  77. HUSSEN N, Zhu L, Tetangco E, Ellison S, et al
    Hepatoptosis in a Patient with Alcoholic Hepatitis.
    Am J Gastroenterol. 2018 Jun 29. pii: 10.1038/s41395-018-0182.
    PubMed    


  78. CUADRADO A, Llerena S, Cobo C, Pallas JR, et al
    Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm.
    Am J Gastroenterol. 2018 Jun 27. pii: 10.1038/s41395-018-0157.
    PubMed     Abstract available


  79. KRAWCZYK M, Gaweda B, Kosnik A, Rejowski S, et al
    Successful DAA-Based Treatment of Hcv-Related Fibrosing Cholestatic Hepatitis After Liver Transplantation Due to a Fulminant Liver Failure.
    Am J Gastroenterol. 2018 Jun 21. pii: 10.1038/s41395-018-0078.
    PubMed    


  80. PHILIPS CA, Paramaguru R, Augustine P
    Severe Alcoholic Hepatitis in a Teetotaler.
    Am J Gastroenterol. 2018 Jun 11. pii: 10.1038/s41395-018-0154.
    PubMed    


  81. SHIN JW, Jung SW, Lee SB, Lee BU, et al
    Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0093.
    PubMed     Abstract available


  82. NOUREDDIN M, Vipani A, Bresee C, Todo T, et al
    NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0088.
    PubMed     Abstract available


    May 2018
  83. SCHMELTZER PA, Russo MW
    Clinical narrative: autoimmune hepatitis.
    Am J Gastroenterol. 2018 May 14. pii: 10.1038/s41395-018-0058.
    PubMed     Abstract available


    April 2018
  84. ZAMOR PJ, Vierling J, Ghalib R, Luketic V, et al
    Elbasvir/grazoprevir in black adults with hepatitis C virus infection: a pooled analysis of phase 2/3 clinical trials.
    Am J Gastroenterol. 2018 Apr 26. pii: 10.1038/s41395-018-0053.
    PubMed     Abstract available


  85. PERRELLA A, Rinaldi L, Galeota-Lanza A, Izzi A, et al
    DAAs and long-term clinical outcome in hepatitis C: the panacea for all diseases still does not exist.
    Am J Gastroenterol. 2018 Apr 24. pii: 10.1038/s41395-018-0062.
    PubMed    


    March 2018
  86. WONG RJ, Jain MK, Therapondos G, Shiffman ML, et al
    Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment.
    Am J Gastroenterol. 2018 Mar 9. pii: 10.1038/s41395-018-0033.
    PubMed     Abstract available


    February 2018
  87. YI W, Pan CQ, Li MH, Wan G, et al
    The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B.
    Am J Gastroenterol. 2018 Feb 27. pii: 10.1038/s41395-018-0010.
    PubMed     Abstract available


    January 2018
  88. WEN JW, Kohn MA, Wong R, Somsouk M, et al
    Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans.
    Am J Gastroenterol. 2018 Jan 30. pii: ajg2017456. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


    December 2017
  89. HUANG YW, Lee CL, Yang SS, Fu SC, et al
    Corrigendum: Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.
    Am J Gastroenterol. 2017 Dec 26. pii: ajg2017494. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  90. BUNCHORNTAVAKUL C, Reddy KR
    HCV Therapy in Decompensated Cirrhosis before or after Liver Transplantation: A Paradoxical Quandary.
    Am J Gastroenterol. 2017 Dec 5. pii: ajg2017435. doi: 10.1038/ajg.2017.
    PubMed    


  91. UMASHANKER R
    Continuing Medical Education Questions: December 2017: Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues.
    Am J Gastroenterol. 2017;112:1789.
    PubMed    


  92. NGUYEN MH, Trinh H, Do S, Nguyen T, et al
    Open Label Study of 8 vs. 12 Weeks of Ledipasvir/Sofosbuvir in Genotype 6 Treatment Naive or Experienced Patients.
    Am J Gastroenterol. 2017;112:1824-1831.
    PubMed     Abstract available


    November 2017
  93. KWO PY, Shiffman ML, Bernstein DE
    The Cochrane Review Conclusion for Hepatitis C DAA Therapies is Wrong.
    Am J Gastroenterol. 2017 Nov 14. doi: 10.1038/ajg.2017.
    PubMed    


  94. SOLLIMA S, Milazzo L, Antinori S, Galli M, et al
    Direct-Acting Antivirals and Mixed Cryoglobulinemia Vasculitis: Long-Term Outcome of Patients Achieving HCV Eradication.
    Am J Gastroenterol. 2017;112:1753-1754.
    PubMed    


  95. LIU X, Shen JJ, Lee JL, Yoo JW, et al
    Cost-Effective but Unaffordable and Unequal Hepatitis C Treatment in the US.
    Am J Gastroenterol. 2017;112:1749.
    PubMed    


  96. FUKUI N, Golabi P, Otgonsuren M, Mishra A, et al
    Demographics, Resource Utilization, and Outcomes of Elderly Patients With Chronic Liver Disease Receiving Hospice Care in the United States.
    Am J Gastroenterol. 2017;112:1700-1708.
    PubMed     Abstract available


    October 2017
  97. WU T, Kwok RM, Tran TT
    Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues.
    Am J Gastroenterol. 2017 Oct 31. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  98. KECK C, Shetty A, Mischen B, Willner I, et al
    Hepatic Splenosis Masquerading as Hepatocellular Carcinoma in a Chronic Hepatitis C Patient.
    Am J Gastroenterol. 2017;112:1493.
    PubMed    


    September 2017
  99. CHON YE, Park JY, Myoung SM, Jung KS, et al
    Corrigendum: Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.
    Am J Gastroenterol. 2017 Sep 12. doi: 10.1038/ajg.2017.
    PubMed    


  100. HUANG R, Yan X, Liu Y, Zhang Z, et al
    Can Transient Elastography Predict Fibrosis Regression in Patients with Chronic Hepatitis B During Long-Term Antiviral Therapy?
    Am J Gastroenterol. 2017;112:1477-1478.
    PubMed    


  101. KOFF RS
    Editorial: Direct Antiviral Agents Eliminate the Age Barrier to Treatment of Chronic Hepatitis C.
    Am J Gastroenterol. 2017;112:1410-1411.
    PubMed     Abstract available


  102. LENS S, Fernandez I, Rodriguez-Tajes S, Hontangas V, et al
    Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease.
    Am J Gastroenterol. 2017;112:1400-1409.
    PubMed     Abstract available


    August 2017
  103. TSENG TC, Liu CJ, Su TH, Yang WT, et al
    Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma.
    Am J Gastroenterol. 2017 Aug 29. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  104. MARTIN P, Fabrizi F
    Editorial: Benefit of Direct-Acting Antiviral Therapy For Cryoglobulinemia due to Hepatitis C Infection.
    Am J Gastroenterol. 2017;112:1309-1310.
    PubMed     Abstract available


  105. EMERY JS, Kuczynski M, La D, Almarzooqi S, et al
    Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia.
    Am J Gastroenterol. 2017;112:1298-1308.
    PubMed     Abstract available


    July 2017
  106. PELLICANO R
    Is Viral Hepatitis Decreasing in the United States?
    Am J Gastroenterol. 2017;112:1170.
    PubMed    


    June 2017
  107. TOYODA H, Kumada T, Tada T
    Hepatitis B Core-Related Antigen: A Possible Indicator for the Termination of Prophylactic Nucleos(t)ide Analogue Therapy in Patients After Immunosuppressive Therapy.
    Am J Gastroenterol. 2017;112:969-970.
    PubMed    


    April 2017
  108. LEE MH, Hsiao TI, Subramaniam SR, Le AK, et al
    HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2017 Apr 25. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  109. OOKA K, Connolly JJ, Lim JK
    Medicaid Reimbursement for Oral Direct Antiviral Agents for the Treatment of Chronic Hepatitis C.
    Am J Gastroenterol. 2017 Apr 4. doi: 10.1038/ajg.2017.
    PubMed    


  110. CHON YE, Park JY, Myoung SM, Jung KS, et al
    Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.
    Am J Gastroenterol. 2017 Apr 4. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  111. GARCIA-SAENZ-DE-SICILIA M, Duvoor C, Altamirano J, Chavez-Araujo R, et al
    Corrigendum: A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis.
    Am J Gastroenterol. 2017;112:666.
    PubMed    


    February 2017
  112. TAKYAR V, Kleiner DE, Koh C
    A Wolf in Sheep's Clothing in the Era of Non-Invasive Staging: Non-Hodgkin's Lymphoma Masquerading as Serologic HCV Cirrhosis.
    Am J Gastroenterol. 2017;112:398-399.
    PubMed    


    January 2017
  113. FARRAYE FA, Melmed GY, Lichtenstein GR, Kane SV, et al
    ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


  114. KWO PY, Cohen SM, Lim JK
    ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
    Am J Gastroenterol. 2017;112:18-35.
    PubMed     Abstract available


    August 2016
  115. TROJAN J, Sarrazin C
    Complete Response of Hepatocellular Carcinoma in a Patient With End-stage Liver Disease treated With Nivolumab: Whishful thinking or Possible?
    Am J Gastroenterol. 2016;111:1208-9.
    PubMed    


    July 2016
  116. DI COSTANZO GG, Marino Marsilia G, Tortora R, Di Costanzo G, et al
    Hepatocellular Carcinoma With Peliosis-Like Change-Mimicking Hemangioma: A LI-RADS Exception.
    Am J Gastroenterol. 2016;111:1038-40.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: